| Gain in the short arm of chromosome 2 (2p+) induces gene overexpression and drug resistance in chronic lymphocytic leukemia: analysis of the central role of XPO1 A Cosson, E Chapiro, N Bougacha, J Lambert, L Herbi, HA Cung, C Algrin, ... Leukemia 31 (7), 1625-1629, 2017 | 70 | 2017 |
| Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53 E Chapiro, E Pramil, M Diop, D Roos-Weil, C Dillard, C Gabillaud, ... Blood, The Journal of the American Society of Hematology 134 (21), 1821-1831, 2019 | 44 | 2019 |
| 14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and small lymphocytic lymphoma A Cosson, E Chapiro, N Belhouachi, HA Cung, B Keren, F Damm, ... Genes, Chromosomes and Cancer 53 (8), 657-666, 2014 | 36 | 2014 |
| Outcomes after intensive care unit admission of patients with newly diagnosed lymphoma C Algrin, S Faguer, V Lemiale, E Lengliné, D Boutboul, S Amorim, ... Leukemia & lymphoma 56 (5), 1240-1245, 2015 | 27 | 2015 |
| Flow cytometry minimal residual disease after allogeneic transplant for chronic lymphocytic leukemia C Algrin, JL Golmard, M Michallet, O Reman, A Huynh, A Perrot, A Sirvent, ... European Journal of Haematology 98 (4), 363-370, 2017 | 19 | 2017 |
| Graft-versus-T-cell lymphoma effect: a sustained CR after tapering immunosuppressive drugs in a patient with angioimmunoblastic T-cell lymphoma in relapse after allogeneic … AC Mamez, L Souchet, D Roos-Weil, M Uzunov, AL Brun, C Algrin, ... Bone Marrow Transplantation 50 (2), 304-306, 2015 | 15 | 2015 |
| Cerebrospinal fluid interleukin (IL)-10 and IL-10: IL-6 ratio as biomarkers for small B-cell lymphoproliferations with leptomeningeal dissemination M Costopoulos, R Kim, S Choquet, K Maloum, C Houillier, C Algrin, ... Seminars in Hematology 55 (4), 179-181, 2018 | 11 | 2018 |
| c‐MYC and p53 expression highlight starry‐sky pattern as a favourable prognostic feature in R‐CHOP‐treated diffuse large B‐cell lymphoma A Bouroumeau, L Bussot, T Bonnefoix, C Fournier, C Chapusot, ... The Journal of Pathology: Clinical Research 7 (6), 604-615, 2021 | 8 | 2021 |
| Immunochemotherapy versus rituximab in anti‐myelin‐associated glycoprotein neuropathy: a report of 64 patients T Nivet, A Baptiste, L Belin, P Ghillani‐Dalbin, C Algrin, S Choquet, ... British Journal of Haematology 198 (2), 298-306, 2022 | 7 | 2022 |
| Neither the patient nor the physician could see anything: Atypical Bing–Neel syndrome JL Bacquet, N Weiss, C Meyniel, C Algrin, S Choquet, V Leblond, ... American Journal of Hematology 91 (8), 858-859, 2016 | 7 | 2016 |
| CYCLON and NPM1 Cooperate within an Oncogenic Network Predictive of R-CHOP Response in DLBCL A Bouroumeau, L Bussot, S Hamaidia, A Garcìa-Sandoval, ... Cancers 13 (23), 5900, 2021 | 5 | 2021 |
| Groupe Francophone de CytogénétiqueHématologique. 14q deletions are associated with trisomy 12, NOTCH1 mutations and unmutated IGHV genes in chronic lymphocytic leukemia and … A Cosson, E Chapiro, N Belhouachi, HA Cung, B Keren, F Damm, ... Genes Chromosomes Cancer 53 (8), 657-66, 2014 | 5 | 2014 |
| Retrospective analysis of a cohort of 41 de novo B-cell prolymphocytic leukemia patients: impact of genetics and targeted therapies (a FILO study) C Algrin, L Pérol, E Chapiro, L Baseggio, K Maloum, C Settegrana, ... Haematologica 108 (6), 1691, 2023 | 4 | 2023 |
| Genetic Characterization of B-Cell Prolymphocytic Leukemia (B-PLL): A Hierarchical Prognostic Model Involving MYC and TP53 Abnormalities. on Behalf of the Groupe Francophone De … E Chapiro, D Roos-Weil, N Bougacha, C Gabillaud, C Dillard, E Pramil, ... Blood 132, 943, 2018 | 4 | 2018 |
| Prognostic impact of somatic NOTCH2 mutation in splenic marginal zone lymphoma C Algrin, G Brisou, K Beldjord, N Mounier, F Berger, L Baseggio, A Verney, ... Blood 122 (21), 4247, 2013 | 4 | 2013 |
| B-Cell prolymphocytic leukemia, a rare lymphoproliferative disorder: analysis of 35 cases, a study on behalf of the French Innovative Leukemia Organization (FILO) C Algrin, E Chapiro, J Saviellis, A Quinquenel, AS Michallet, D Ghez, ... Blood 130, 4310, 2017 | 3 | 2017 |
| The Gain of the Short Arm of Chromosome 2 (2p+) Induces XPO1 Overexpression and Drug Resistance in Chronic Lymphocytic Leukemia A Cosson, E Chapiro, J Lambert, HA Cung, C Algrin, F Damm, ... Blood 126 (23), 492, 2015 | 3 | 2015 |
| Interim-positron emission tomography with [18F] fluorodeoxyglucose (interim-PET) evaluation in mediastinal lymphoma including Hodgkin lymphoma (HL) and primary mediastinal … C Algrin, N Bérenger, S Chevret, L Vercellino, C de Bazelaire, P Brice, ... Blood 116 (21), 2860, 2010 | 3 | 2010 |
| To Dose or Not to Dose: Are IL-10 and IL-6 Accurate Biomarkers to Detect Leptomeningeal Involvement in Small B-Cell Lymphoproliferation? R Kim, M Costopoulos, S Choquet, K Maloum, C Algrin, K Hoang-Xuan, ... Blood 126 (23), 3878, 2015 | 2 | 2015 |
| Venous thromboembolism during systemic inflammatory and autoimmune diseases associated with myelodysplastic syndromes, chronic myelomonocytic leukaemia and myelodysplastic … MP de Ponfilly-Sotier, V Jachiet, Y Benhamou, C Lahuna, B De Renzis, ... Clinical and experimental rheumatology 40 (7), 1336-1342, 2022 | 1 | 2022 |
